Help us reach $1,000,000! Match My Donation

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

Aiming the Immune System at Brain Cancer

In this webinar designed for patients and caregivers, David A. Reardon, M.D., discussed current immunotherapy treatment options for patients with brain cancer, and how close we are to making these treatments available to more patients.

David A. Reardon, M.D., currently serves as Clinical Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute and previously served as the Associate Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center. His work includes using innovative clinical therapies to improve cure rates in patients with brain and spinal tumors, with particular focus on immunotherapies.

This webinar is part of the Cancer Research Institute's webinar series, "Cancer Immunotherapy and You," which are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&A. This webinar was generously supported by Agenus. For more information on this webinar, or to register for upcoming webinars, please visit

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111

(800) 992-2623(212) 832-9376Staff Directory

Stay Connected with CRI

Follow us